HC Wainwright & Co. Reiterates Buy on RenovoRx, Maintains $3 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.3%

Neg 0% Neu 86.3% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates RenovoRx (NASDAQ:RNXT) with a Buy and maintains $3 price target.